Medcaptain (02041.HK): Public offering closes today, oversubscribed by over 323 times

NewTimeSpace News: Medcaptain (02041.HK) closed its public offering at 12:00 noon on 2 September 2026. As of 11:50 a.m., total margin financing amounted to approximately HKD 19.4 billion, representing a margin financing multiple of approximately 323.32 times. The Company is expected to be listed on 7 September 2026.

According to the offering documents, the offer price was set at HKD 15.42 per share, with a total of 38,910,600 shares offered in the global offering, comprising 3,891,100 shares (10%) under the public offering and 35,019,500 shares (90%) under the international placing. Each board lot comprises 100 shares, with an application fee of approximately HKD 1,557.55. The offering represents approximately 7.22% of the enlarged share capital, with approximately 539 million shares in issue after the listing.

Total gross proceeds amount to approximately HKD 600 million, and after deducting listing expenses of approximately HKD 104 million, net proceeds amount to approximately HKD 496 million. In terms of the use of proceeds, approximately 35% (HKD 173.7 million) will be used for R&D to enrich the product pipeline, approximately 20% for developing manufacturing centres to expand production capacity, approximately 20% for enhancing sales and marketing capabilities, approximately 10% for global strategic investments and acquisitions, approximately 5% for upgrading IT infrastructure and digital platforms, and approximately 10% for working capital and other general corporate purposes.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.